Cholestasis in Extreme Low Birth Weight Infants (ELBW) - Possible Influences of a Change in Nutrition Policy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 122
- 主要终点
- Cholestasis
研究概览
简要总结
Parenteral nutrition associated liver disease (PNALD) in preterm neonates is characterized by early occurrence of intrahepatic cholestasis (parenteral nutrition associated cholestasis (PNAC).
Extreme low birth weight infants (ELBW, birth weight < 1000 g) are at increased risk for development of PNAC.
Important factors implicated in the aetiology of PNAC are high caloric parenteral nutrition using amino acids or dextrose, but also intravenous lipids and infections in particular necrotizing enterocolitis (NEC).
Due to a change of paradigm a more aggressive nutrition with early use of parenteral amino acids/lipids and early fortification of mothers milk or alternatively high caloric preterm formula is warranted. Accordingly - in line with the existing expert opinion and evidence - the feeding policy at the neonatal care units of our hospital was adapted.
Evidence exists that PNAC might be caused by the use of high concentrations of amino acids and lipids in parenteral nutrition. Furthermore NEC is associated with high osmotic feeds. Therefore the incidence of PNAC might be increased directly and indirectly after introducing the new feeding policy.
The investigators therefore aim at retrospectively investigating the incidence of PNAC before and after introduction of a feeding policy of "aggressive nutrition" for ELBW infants.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 1 Hour(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ELBW infants below 1000 Gram birth weight
- •Born in house between January 2005 - December 2006 ("before") and July 2007- June 2009 ("after")
排除标准
- •signs of cholestasis at birth
- •Death or transfer before 28 Days of life
- •Diseases associated with Cholestasis
结局指标
主要结局
Cholestasis
时间窗: Assessment of bilirubin levels at least every second week from birth (0 weeks) to discharge (i.e. up to an average of 12 weeks)
Conjugated Bilirubin \> 1.5 mg/dl at two measurements
次要结局
- Growth(At study entry (after birth, 0 weeks) and discharge (i.e. at an average of 12 weeks))
研究者
Nadja Haiden,MD
PD Dr.
Medical University of Vienna
